Locoregional infusion of EGFR806-CAR T cells for recurrent or refractory pediatric CNS tumors: Results of the completed BrainChild02 phase 1 clinical trialJuliane Gust, Julie R. Park, Rebecca Ronsley et al.|Neuro-Oncology|2025Cited by 16